Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Forte Biosciences, Inc. before investing.

In this article, we go over a few key elements for understanding Forte Biosciences, Inc.’s stock price such as:

• Forte Biosciences, Inc.’s current stock price and volume
• Why Forte Biosciences, Inc.’s stock price changed recently
• Upgrades and downgrades for FBRX from analysts
• FBRX’s stock price momentum as measured by its relative strength

About Forte Biosciences, Inc. (FBRX)

Before we jump into Forte Biosciences, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Want to learn more about Forte Biosciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Forte Biosciences, Inc..

Forte Biosciences, Inc.’s Stock Price as of Market Close

As of March 31, 2026, 4:00 PM, CST, Forte Biosciences, Inc.’s stock price was $25.900.

Forte Biosciences, Inc. is down 1.6% from its previous closing price of $26.320.

During the last market session, Forte Biosciences, Inc.’s stock traded between $25.440 and $28.030. Currently, there are approximately 17.79 million shares outstanding for Forte Biosciences, Inc..

Forte Biosciences, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Forte Biosciences, Inc. Stock Price History

Forte Biosciences, Inc.’s (FBRX) price is currently down 14.3% so far this month.

During the month of March, Forte Biosciences, Inc.’s stock price has reached a high of $32.970 and a low of $22.010.

Over the last year, Forte Biosciences, Inc. has hit prices as high as $35.620 and as low as $4.900. Year to date, Forte Biosciences, Inc.’s stock is down 5.02%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Forte Biosciences, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 31, 2026, there were 2 analysts who downgraded Forte Biosciences, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Forte Biosciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Forte Biosciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Forte Biosciences, Inc. (FBRX) by visiting AAII Stock Evaluator.

Relative Price Strength of Forte Biosciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 31, 2026, Forte Biosciences, Inc. has a weighted four-quarter relative price strength of 27.02%, which translates to a Momentum Score of 92 and is considered to be Very Strong.

Want to learn more about how Forte Biosciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Forte Biosciences, Inc. Stock Price: Bottom Line

As of March 31, 2026, Forte Biosciences, Inc.’s stock price is $25.900, which is down 1.6% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Forte Biosciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.